COPT Defense Properties Valuation
Is WX7 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of WX7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: WX7 (€31.2) is trading below our estimate of fair value (€53.26)
Significantly Below Fair Value: WX7 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for WX7?
Key metric: As WX7 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is WX7's PE Ratio? | |
|---|---|
| PE Ratio | 27x |
| Earnings | US$136.97m |
| Market Cap | US$3.75b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 8.2x |
| Enterprise Value/EBITDA | 16.9x |
| PEG Ratio | 6.8x |
Price to Earnings Ratio vs Peers
How does WX7's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 31.1x | ||
HIW Highwoods Properties | 24.3x | -32.2% | US$3.5b |
8954 ORIX JREIT | 20x | n/a | JP¥460.1b |
EMBASSY Embassy Office Parks REIT | 16x | -17.3% | ₹354.5b |
HABA Hamborner REIT | 64.2x | 10.8% | €525.5m |
WX7 COPT Defense Properties | 27x | 4.0% | €3.7b |
Price-To-Earnings vs Peers: WX7 is good value based on its Price-To-Earnings Ratio (27x) compared to the peer average (31.1x).
Price to Earnings Ratio vs Industry
How does WX7's PE Ratio compare vs other companies in the Global Office REITs Industry?
| 3 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 3 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: WX7 is expensive based on its Price-To-Earnings Ratio (27x) compared to the Global Office REITs industry average (21x).
Price to Earnings Ratio vs Fair Ratio
What is WX7's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 27x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate WX7's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €31.00 | €33.52 +8.1% | 4.5% | €35.15 | €31.35 | n/a | 7 |
| Nov ’25 | €29.20 | €31.24 +7.0% | 7.0% | €34.14 | €27.68 | n/a | 7 |
| Oct ’25 | €27.60 | €28.66 +3.8% | 3.5% | €29.55 | €26.87 | n/a | 8 |
| Sep ’25 | €26.80 | €28.14 +5.0% | 8.1% | €29.86 | €23.52 | n/a | 10 |
| Aug ’25 | €26.60 | €27.15 +2.1% | 10.0% | €30.58 | €23.17 | n/a | 10 |
| Jul ’25 | €23.00 | €26.20 +13.9% | 8.1% | €30.55 | €23.15 | n/a | 10 |
| Jun ’25 | €22.60 | €26.20 +15.9% | 8.1% | €30.55 | €23.15 | n/a | 10 |
| May ’25 | €22.40 | €26.40 +17.8% | 8.1% | €30.78 | €23.32 | n/a | 10 |
| Apr ’25 | €22.20 | €26.16 +17.8% | 8.3% | €30.72 | €23.28 | n/a | 10 |
| Mar ’25 | €22.60 | €26.43 +17.0% | 7.2% | €30.50 | €24.03 | n/a | 10 |
| Feb ’25 | €21.40 | €26.05 +21.7% | 7.7% | €30.16 | €23.76 | n/a | 10 |
| Jan ’25 | €23.00 | €25.72 +11.8% | 7.7% | €29.89 | €23.55 | n/a | 10 |
| Dec ’24 | €23.40 | €25.83 +10.4% | 8.7% | €30.12 | €21.90 | n/a | 10 |
| Nov ’24 | €21.40 | €27.25 +27.4% | 11.3% | €33.12 | €22.71 | €29.20 | 10 |
| Oct ’24 | €22.40 | €27.51 +22.8% | 11.0% | €32.83 | €21.57 | €27.60 | 9 |
| Sep ’24 | €24.20 | €27.23 +12.5% | 11.0% | €32.49 | €21.35 | €26.80 | 9 |
| Aug ’24 | €23.40 | €26.10 +11.5% | 11.7% | €31.87 | €20.94 | €26.60 | 9 |
| Jul ’24 | €21.60 | €26.45 +22.5% | 11.6% | €32.42 | €22.23 | €23.00 | 9 |
| Jun ’24 | €20.80 | €26.31 +26.5% | 12.0% | €32.62 | €22.37 | €22.60 | 9 |
| May ’24 | €20.40 | €26.02 +27.5% | 11.2% | €31.76 | €21.78 | €22.40 | 9 |
| Apr ’24 | €21.40 | €26.84 +25.4% | 10.1% | €32.28 | €23.06 | €22.20 | 10 |
| Mar ’24 | €24.00 | €28.73 +19.7% | 8.3% | €33.08 | €23.63 | €22.60 | 10 |
| Feb ’24 | €25.00 | €28.01 +12.1% | 8.6% | €32.24 | €23.03 | €21.40 | 12 |
| Jan ’24 | €24.20 | €28.72 +18.7% | 8.3% | €32.96 | €24.49 | €23.00 | 12 |
| Dec ’23 | €25.20 | €28.82 +14.4% | 8.4% | €33.25 | €24.70 | €23.40 | 12 |
| Nov ’23 | €26.60 | €30.28 +13.8% | 9.9% | €34.12 | €25.09 | €21.40 | 12 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Argan
€1.7b
Engages in designing, building, developing, owning, leasing, and managing logistical platforms in France.
871
€63.70
7D
-3.0%
1Y
-16.2%
Allied Properties Real Estate Investment Trust
CA$2.5b
Allied is a leading owner-operator of distinctive urban workspace in Canada's major cities.
5G8
CA$12.18
7D
-0.4%
1Y
1.7%
NSI
€376.7m
A specialist commercial property investor and the only listed real estate investment trust (REIT) focused on well-located offices in economic growth regions in The Netherlands.
N4RN
€19.46
7D
0%
1Y
12.4%